Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
11,817,237
-
Share change
-
-1,269,381
-
Total reported value
-
$20,196,000
-
Price per share
-
$1.65
-
Number of holders
-
30
-
Value change
-
-$4,061,095
-
Number of buys
-
8
-
Number of sells
-
17
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2019
As of 30 Jun 2019,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,817,237 shares.
The largest 10 holders included
STONEHILL CAPITAL MANAGEMENT LLC, Paradice Investment Management LLC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, HEARTLAND ADVISORS INC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, Lapides Asset Management, LLC, Adirondack Research & Management Inc., and MORGAN STANLEY.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.